Great to catch up with @NickMedhurst this morning and find out more about the tool @goodtrials have developed to support the application of the key principles of good RCTs. #ICTMC2024 #UKCTUNetwork

📢 Now at #RECOVERYMeeting2024: Dr Evelyne Kestelyn, Head of @OUCRU_CTU, redefines what “good” looks like in #ClinicalTrials Join us to explore new approaches for faster trials & better patient outcomes. #RECOVERYTrial #GoodTrials

Interested...? Have a look at the @goodtrials guidance here: https://t.co/5rDv6u0jVI @MartinLandray @NickMedhurst

🚨 Did you miss our webinar on "Returning to the Principles of Good Randomized Clinical Trials (RCTs)"? Our panel explored how the @goodtrials Guidance can enable informative, ethical and efficient RCTs 📃 Watch a recording of the event and read more: https://t.co/niLr5orUgd

Curious about elevating healthcare evidence through good Randomized Clinical Trials (RCTs)? Join the webinar: Returning to the Principles of Good RCTs. In English, Spanish, Portuguese and French 6 February 2024, 11:30 UCT Register: https://t.co/pc92bufa26 With @goodtrials

📢 New! Do you work in randomized clinical trials (RCTs)? We're hosting a webinar with @info_TGHN on "Returning to the Principles of Good RCTs” Join @goodtrials to learn about how new guidance can enable informative, ethical, and efficient RCTs Find out more 👇

Read our commentary on GCP E6(R3) guidelines submitted to @EMA_News. Backed by Coalition for Reducing Bureaucracy in Clinical Trials and @Biomedalliance, representing 50+ medical societies & patient advocacy groups as well as 400+ healthcare professionals.

🚨It's the tweet you've been waiting for - I'm hiring! We're looking for two Senior Policy Officers to join Wellcome's policy team. 💸£38k 🗓️Full time, permanent 🏢Hybrid (2 days pw in London) ⏲️Deadline 12 Oct 🧵below on what we're looking for... https://t.co/IoD1DmtD46

Thanks for having me - great to talk about the https://t.co/StLX6aY6wB work and to discuss ICH GCP E6 with colleagues.

News alert! We’ve submitted commentaries to national regulators responding to @ICH_news draft E6(R3) guideline. Our submission to @FDA https://t.co/nYaECxqVxg Comment periods still open for other regulators. Interested to be a co-signatory? Write to us at contact@goodtrials.org

The #GoodTrials guidance discusses the importance of proportionate, efficient and reliable capture of #data in #RCTs. Naomi Waithira from @MORUBKK highlights things to consider and things to avoid when planning data collection in a #clinicaltrial. #GoodTrialsGrapevine

A year ago I thought it might be fun to start the week with a tweet about some aspect of trial, or related, methodology - which I have tagged with #MethodologyMonday. 50+ topics later, I hope you have found some of them useful … here is a list of the topics covered so far 1/

📰The Aug edition of #InsideGoodTrials is out! https://t.co/lOlMsi6Gs2 Highlights: @WHO public consultation of its draft #clinicaltrials guidance & @Collaboratory1 free-to-attend webinar discussing @ICH_news draft #GCP guidelines this Friday Subscribe: https://t.co/QDuA8lfyyp

@ADVANCE_ID @AHRI_NEWS @OUCRU_Programme @INFO_TGHN @wellcometrust

📢@WHO seeks public input on draft guidance for #clinicaltrials! Proud that our Guidance contributed to this initiative with its principles forming the basis of a key section and core themes amplified through the document. Deadline to take part: 15 Sep https://t.co/HqgQTWkmke

It was a privilege to talk to Alzheimer’s patient Mike Colley and his son Mark about the donanemab trial which they feel has given the family hope. There would be no medical advances unless patients volunteered for trials.

#Collaboration and #transparency are pivotal to maximizing benefit from research. In today’s #GoodTrialsGrapevine, @InfectiousMoYin of @ADVANCE__ID discusses the benefits of collaboration to boost the efficiency & quality of #clinicaltrials in Asia. 👉 https://t.co/c8zwItEPsm

⏰ Just over 48 hours left to apply for these great roles at @GoodTrials. Come and join a great team and a global community working to improve healthcare worldwide.

In #ACTEU's workshop today @GoldLabCharite discussed the priorities for a thriving #clinicaltrials landscape- good #trialdesign, principles-based guidance, appropriate infrastructure, continuous utilization. Join @MartinLandray tomorrow on ACTEU's support for multinational trials

This morning at #ACTEU workshop: @MartinLandray on the importance of an inclusive platform, which will allow us to tackle challenges & capitalize on opportunities more effectively. Principles-based guidance will provide the foundation for better trials. 👉 https://t.co/R6JaE7ESu3